BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9022281)

  • 21. Evidence for alternate points of attachment for alpha-MSH and its stereoisomer [Nle4, D-Phe7]-alpha-MSH at the melanocortin-1 receptor.
    Frändberg PA; Muceniece R; Prusis P; Wikberg J; Chhajlani V
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1266-71. PubMed ID: 8060302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced binding and inertness to dehalogenation of alpha-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate.
    Garg PK; Alston KL; Welsh PC; Zalutsky MR
    Bioconjug Chem; 1996; 7(2):233-9. PubMed ID: 8983345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calmodulin-binding peptides interfere with melanocyte-stimulating hormone receptor activity and stimulate adenosine 3',5'-monophosphate production in M2R mouse melanoma cells.
    Eshel Y; Salomon Y
    Endocrinology; 1994 Jan; 134(1):177-85. PubMed ID: 8275931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
    Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
    J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
    Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
    J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
    Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
    Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional induction of the melanocyte-stimulating hormone receptor in brain metastases of murine K-1735 melanoma.
    Radinsky R; Beltran PJ; Tsan R; Zhang R; Cone RD; Fidler IJ
    Cancer Res; 1995 Jan; 55(1):141-8. PubMed ID: 7805024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin that "irreversibly" activates melanoma tyrosinase.
    Hadley ME; Abdel Malek ZA; Marwan MM; Kreutzfeld KL; Hruby VJ
    Endocr Res; 1985; 11(3-4):157-70. PubMed ID: 3009169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of brain melanocortin receptors suggested by differential ligand binding in situ.
    Tatro JB; Entwistle ML
    Brain Res; 1994 Jan; 635(1-2):148-58. PubMed ID: 8173950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene.
    Chluba-de Tapia J; Bagutti C; Cotti R; Eberle AN
    J Cell Sci; 1996 Aug; 109 ( Pt 8)():2023-30. PubMed ID: 8856498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanotropic peptide receptors: membrane markers of human melanoma cells.
    Jiang J; Sharma SD; Fink JL; Hadley ME; Hruby VJ
    Exp Dermatol; 1996 Dec; 5(6):325-33. PubMed ID: 9028794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of anti-inflammatory alpha-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells.
    Lyson K; Ceriani G; Takashima A; Catania A; Lipton JM
    Neuroimmunomodulation; 1994; 1(2):121-6. PubMed ID: 7489322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres.
    Lu W; Xiong C; Zhang G; Huang Q; Zhang R; Zhang JZ; Li C
    Clin Cancer Res; 2009 Feb; 15(3):876-86. PubMed ID: 19188158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of alpha-melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti.
    Siegrist W; Drozdz R; Cotti R; Willard DH; Wilkison WO; Eberle AN
    J Recept Signal Transduct Res; 1997; 17(1-3):75-98. PubMed ID: 9029482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA.
    Chhajlani V; Wikberg JE
    FEBS Lett; 1992 Sep; 309(3):417-20. PubMed ID: 1516719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanocortin probes for the melanoma MC1 receptor: synthesis, receptor binding and biological activity.
    Erskine-Grout ME; Olivier GW; Lucas P; Sahm UG; Branch SK; Moss SH; Notarianni LJ; Pouton CW
    Melanoma Res; 1996 Apr; 6(2):89-94. PubMed ID: 8791265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
    Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
    Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desensitization of melanotropin receptors in COS-7 cells.
    Polgar WE; Bitler CM; Toll L
    Life Sci; 1996; 58(15):1223-9. PubMed ID: 8614275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of the MSH receptor among B16 murine melanoma subclones.
    SolcĂ  FF; Salomon Y; Eberle AN
    J Recept Res; 1991; 11(1-4):379-90. PubMed ID: 1653343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanotropin receptors in the brain are differentially distributed and recognize both corticotropin and alpha-melanocyte stimulating hormone.
    Tatro JB
    Brain Res; 1990 Dec; 536(1-2):124-32. PubMed ID: 1964830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.